Stock overview
Nurix Therapeutics
Explore the company, reported ownership, price history, and available source evidence.
NURIX THERAPEUTICS (NRIX) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $23.01
- · NRIX
- Tracked holders
- 3 funds
- Latest available 13F per fund
NRIX · USD
Price
$23.01
-$11.26
(-32.86%)
over selected range
Close · Sep 25, 2026
Market closed
1255 stored daily closes
$23.01
Sep 25, 2026
- Range low
- $4.25
- Range high
- $34.50
- Observations
- 1255
- Session date
- Sep 25, 2026
Sep 27, 2021–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Baker Bros. Advisors largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | — | $113,016,569 | 0.57% |
| General Atlantic position history Q2 2026 · filed Aug 14, 2026 · SEC filing | −26% 26'Q2 | $73,560,808 | 2.53% |
| ARK Investment Management position history Q2 2026 · filed Aug 14, 2026 · SEC filing | +4% 26'Q2 | $43,502,930 | 0.28% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market